Brush Up on Biosimilars

January 2025

You’ll see more biosimilar use...now that there are over 60 available in the US. And over 16 were approved in 2024 alone.

For example, there are now several biosimilars approved for ustekinumab (Stelara)...with ustekinumab-kfce (Yesintek) being the latest.

Keep in mind, biosimilars aren’t generics. It’s not possible to create an exact copy of the original reference product...since biologics contain larger, more complex molecules than most traditional drugs.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Pertussis Reduce Pertussis Rates With Vaccination and Antibiotics
Immunizations Clarify the Latest Meningococcal Vaccine Recommendations
Biosimilars Brush Up on Biosimilars
Interactions CYP’n on Grapefruit Juice With Statins – Do We Still Avoid?
Parkinson's Disease Choose the Best Carbidopa/Levodopa Product for Your Patient
Cardiology Recognize Key Meds for Patients With MINOCA
Education and Training Use Strategies to Precept Gen Z Learners
NatMed Spotlight Put Claims About Bovine Colostrum in Perspective

Brush Up on Biosimilars

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents